Pfizer expects updated COVID-19 vaccine data for kids under 5 by April

Pfizer Inc expects the latest results from a clinical trial for kids under the age of 5 of the COVID-19 vaccine it developed with Germany’s BioNTech SE by April, a top company scientist said on Wednesday. “The study has been amended to give a third dose to everybody who’s less than five at least eight weeks after their last vaccination,” Dr. Alejandra Gurtman, a Pfizer … Continue reading Pfizer expects updated COVID-19 vaccine data for kids under 5 by April